Rare Disease Treatment Market: Rising Prevalence of Rare Genetic Disorders Boosts Demand
The global rare disease treatment market is on a trajectory of substantial growth, with its valuation expected to nearly double from US$239.3 billion in 2025 to US$490.6 billion by 2032. This growth, at a robust compound annual growth rate (CAGR) of 10.8%, highlights the increasing importance and investment in healthcare innovation, particularly in the domain of rare and orphan diseases. This upward trend reflects both growing awareness and advancements in biotechnology, genomics, and personalized medicine.